News Theralink Technologies, Inc.

Equities

THER

US88339Q1094

Delayed OTC Markets Other stock markets 08:12:37 20/05/2024 pm IST			5-day change	1st Jan Change
0.0007 ^USD	0.00%		0.00%	-53.33%

06/05	Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.	CI
20/02	Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.	06/05	CI
Theralink Technologies : Accelaration/Increase of Financial Obligation - Form 8-K	07/03	PU
Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	21/02	CI
Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	06/01	CI
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates	18/12	AQ
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4	14/11	AQ
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board	03/11	AQ
Theralink Technologies, Inc. Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute?s Molecular Tumor Board	03/11	CI
Four Penny Stocks That Might Move On News (EPAZ, THER, SDNR, HNRC)	05/23/05	AQ
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023	04/23/04	AQ
Theralink Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	22/23/22	CI
IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors	26/23/26	CI
Theralink Technologies, Inc. Announces Chief Executive Officer Changes	27/23/27	CI
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer	27/23/27	AQ
Theralink Technologies, Inc. Appoints Mick Ruxin as Chief Medical Officer	27/23/27	CI
Theralink Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	16/23/16	CI
Theralink Technologies, Inc. entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. for $0.9 million in a reverse merger transaction.	15/23/15	CI
Theralink Technologies, Inc. Announces Termination of Thomas Chilcott as Treasurer and Secretary	12/23/12	CI
Theralink Technologies, Inc. Announces CFO Changes	12/23/12	CI
Theralink Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University	04/23/04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Theralink Technologies, Inc.

Equities

THER

US88339Q1094

Summary

Filters